Cover Image
Market Research Report

Global Flow Cytometry Market Growth, Trends & Forecast (2017 - 2022)

Published by Mordor Intelligence LLP Product code 390840
Published Content info 205 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Flow Cytometry Market Growth, Trends & Forecast (2017 - 2022)
Published: January 24, 2017 Content info: 205 Pages
Description

Description

The Global Flow Cytometry Market has been estimated at USD XX billion in 2015 and is estimated to reach USD XX billion by 2020, at a CAGR of XX% during the forecast period from 2015 to 2021. Flow cytometry is a technology that is used to analyze the physical and chemical characteristics of particles in a fluid as it passes through at least one laser. Cell components are fluorescently labeled and then excited by the laser to emit light at varying wavelengths.

Flow cytometry has evolved from a promising new technology to an indispensable tool and its market is seeing a boom because of its application in the diagnosis of various disorders like hematological disorders, malignancies and various infections.

The market is driven by a number of factors like stem cell research booming the market, emergence of new technologies in the field of flow cytometry, increase in its application in clinical research and the continuous product innovation in reagents to aid diagnosis. However, the market is restrained by the lack of awareness about the potential benefits of the technique, the cost of the instrument, reluctance among the medical consultants of developing countries to adopt a new technology like flow cytometry and the reagent based complexities.

The Global flow cytometry market is broadly segmented based on the type of product, technology, application and the end users. Based on the products itfurther segmented into Instruments (Flow cytometers, centrifuge, cell preparation systems), systems and kits, reagents, Instrument support reagent, fluorospheres and software. Based on technology it is segmented as cell based and bead based flow cytometry. Based on application it is segmented as clinical application (oncology, detection of minimal residue disease, organ transplantation, stem cell, HIV, blood transfusion) and life science research and development (Immunophenotyping, cell sorting, cell cycle analysis, apoptosis, cell proliferation assay and Intracellular calcium flux). Based on end users it is segments as hospitals, academia, biotechnology, pharmaceuticals and clinical research organizations.

Based on geographical location, the flow cytometry market can be divided into North America (USA, Canada, and Mexico), Europe (France, UK, Germany, Spain, Portugal, Scandinavia, BENELUX and Italy), Asia-Pacific (India, China, Japan, South Korea and Australia), Middle East and Africa (UAE, Saudi Arabia) and Latin America (Brazil, Argentina).

The ever increasing rise of HIV and cancer cases and the increasing use of flow cytometry in drug discovery are some of the opportunities for the market to grow. The high maintenance and operational cost and the lack of awareness among the end-users about the use of the instrument are some of the challenges for the market players. The key players in the flow cytometry market are Becton, Dickinson and Company, Beckman Coulter, EMD Millipore, Bio-Rad Laboratories, Luminex Corporation among many others.

Key Deliverables

Market analysis for the global Flow Cytometry Market, with region specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale

Extensively researched competitive landscape section with profiles of major companies along with their market shares

Identification and analysis of the macro and micro factors that affect the Global Flow Cytometry Market

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Table of Contents

Table of Contents

1. INTRODUCTION

  • 1.1 Study deliveratives
  • 1.2 Market Definition
  • 1.3 Sizing Units
  • 1.4 Base Currency
  • 1.5 Review and forecasr period years
  • 1.6 General Study Assumptions

2. RESEARCH METHODOLOGY

  • 2.1 Introduction
  • 2.2 Analysis Methodology
  • 2.3 Econometric forecast models
  • 2.4 Research Assumptions

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW AND INDUSTRY TRENDS

  • 5.1 Current market scenario
  • 5.2 Technology Overview
  • 5.3 New developments in therapeutics
  • 5.4 Investment analysis
  • 5.5 Porters Five Force Analysis
    • 5.5.1 Bargaining Power of suppliers
    • 5.5.2 Bargaining power of buyers
    • 5.5.3 Degree of competition
    • 5.5.4 Threat of substitution
    • 5.5.5 Threat of new entrants

6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Stem cell research booming the market growth
    • 6.1.2 Emergence of new technologies in the field of flow cytometry
    • 6.1.3 Increasing applications of Flow Cytometry in Clinical research
    • 6.1.4 Product innovation in reagents for diagnostics
  • 6.2 Market Restraints
    • 6.2.1 Lack of awareness about the potential benefits of flow cytometry techniques
    • 6.2.2 Expensive equipments hindering the growth of the market
    • 6.2.3 Reluctance among the medical consultants of developing countries to adopt a new technology like flow cytometry
    • 6.2.4 Reagent based complexities
  • 6.3 Market Opportunities
    • 6.3.1 Increasing rise of HIV and Cancer cases
    • 6.3.2 Increasing use in drug discovery
  • 6.4 Key Challenges
    • 6.4.1 High on maintenance and operational costs
    • 6.4.2 Lack of end-user awareness about the utility of instrument

7. Global Flow Cytometry Market Segmentation

  • 7.1 By Type of Product
    • 7.1.1 Instruments
      • 7.1.1.1 Flow Cytometers
      • 7.1.1.2 Centrifuges
      • 7.1.1.3 Cell preparation Systems
      • 7.1.1.4 Others
    • 7.1.2 Systems and Kits
    • 7.1.3 Reagents
    • 7.1.4 Instrument Support Reagents
    • 7.1.5 Fluorospheres
    • 7.1.6 Softwares
    • 7.1.7 Others
  • 7.2 By technology
    • 7.2.1 Cell based Flow Cytometry
    • 7.2.2 Bead based Flow Cytometry
    • 7.2.3 Others
  • 7.3 By Application
    • 7.3.1 Clinical Applications
      • 7.3.1.1 Oncology
      • 7.3.1.2 detection of minimal Residue disease
      • 7.3.1.3 Organ Transplantation
      • 7.3.1.4 Stem Cell
      • 7.3.1.5 HIV
      • 7.3.1.6 Blood Transfusion
    • 7.3.2 Life Sciences and Biotechnology (Research and Development)
      • 7.3.2.1 Immunophenotyping
      • 7.3.2.2 Cell Sorting
      • 7.3.2.3 Cell cycle analysis
      • 7.3.2.4 Apoptosis
      • 7.3.2.5 Cell proliferation Assay
      • 7.3.2.6 Intracellular Calcium flux
    • 7.3.3 Others
  • 7.4 By End Users
    • 7.4.1 Hospitals
    • 7.4.2 Academia
    • 7.4.3 Biotechnology
    • 7.4.4 Pharmaceuticals
    • 7.4.5 CRO
    • 7.4.6 Others

8. Global Flow Cytometry Market by Geography - Regional shares and forecast

  • 8.1 North America
    • 8.1.1 Introduction
    • 8.1.2 USA
    • 8.1.3 Canada
    • 8.1.4 Mexico
    • 8.1.5 Rest of North America
  • 8.2 Europe
    • 8.2.1 Introduction
    • 8.2.2 France
    • 8.2.3 UK
    • 8.2.4 Germany
    • 8.2.5 Spain and Portugal
    • 8.2.6 Italy
    • 8.2.7 Scandinavia
    • 8.2.8 BENELUX
    • 8.2.9 Rest of Europe
  • 8.3 Asia-Pacific
    • 8.3.1 Introduction
    • 8.3.2 India
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 Australia and New Zealand
    • 8.3.7 Rest of Asia Pacific
  • 8.4 Middle East and Africa
    • 8.4.1 Introduction
    • 8.4.2 GCC
    • 8.4.3 Egypt
    • 8.4.4 Rest of Middle East and Africa
  • 8.5 Latin America
    • 8.5.1 Introduction
    • 8.5.2 Brazil
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America

9. COMPETITIVE LANDSCAPE

  • 9.1 Mergers & Acquisitions
  • 9.2 New Product Launches
  • 9.3 Agreements, Collaborations & Partnerships

10. KEY VENDORS

  • 10.1 Becton, Dickinson and Company
  • 10.2 Beckman Coulter
  • 10.3 EMD Millipore
  • 10.4 Life Technologies
  • 10.5 Bio-Rad Laboratories
  • 10.6 Miltenyi Biotech
  • 10.7 Partec GMBH
  • 10.8 TTP Labtech Ltd
  • 10.9 Luminex Corporation

11. Analyst outlook for Investment Opportunities

12. Future outlook of the market

13. APPENDIX

  • 13.1 Abbrevations
  • 13.2 Bibliography
  • 13.3 Disclaimer
Back to Top